ID: ALA3326319

Max Phase: Preclinical

Molecular Formula: C17H15NO3

Molecular Weight: 281.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOc1cccc(-c2cc(=O)c3ccccc3o2)c1N

Standard InChI:  InChI=1S/C17H15NO3/c1-2-20-15-9-5-7-12(17(15)18)16-10-13(19)11-6-3-4-8-14(11)21-16/h3-10H,2,18H2,1H3

Standard InChI Key:  RPRXTMMATKGDLA-UHFFFAOYSA-N

Associated Targets(non-human)

Dual specificity mitogen-activated protein kinase kinase MEK1/2 15 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 281.31Molecular Weight (Monoisotopic): 281.1052AlogP: 3.44#Rotatable Bonds: 3
Polar Surface Area: 65.46Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.23CX LogP: 2.34CX LogD: 2.34
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.75Np Likeness Score: 0.16

References

1. Redwan IN, Dyrager C, Solano C, Fernández de Trocóniz G, Voisin L, Bliman D, Meloche S, Grøtli M..  (2014)  Towards the development of chromone-based MEK1/2 modulators.,  85  [PMID:25078316] [10.1016/j.ejmech.2014.07.018]

Source